[go: up one dir, main page]

AU2003251149A1 - Inhibitors of the ephrin/ephb receptor interaction - Google Patents

Inhibitors of the ephrin/ephb receptor interaction

Info

Publication number
AU2003251149A1
AU2003251149A1 AU2003251149A AU2003251149A AU2003251149A1 AU 2003251149 A1 AU2003251149 A1 AU 2003251149A1 AU 2003251149 A AU2003251149 A AU 2003251149A AU 2003251149 A AU2003251149 A AU 2003251149A AU 2003251149 A1 AU2003251149 A1 AU 2003251149A1
Authority
AU
Australia
Prior art keywords
ephrin
inhibitors
receptor interaction
ephb receptor
ephb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003251149A
Inventor
Isabella Gavazzi
Stephen Mcmahon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Publication of AU2003251149A1 publication Critical patent/AU2003251149A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003251149A 2002-07-03 2003-07-03 Inhibitors of the ephrin/ephb receptor interaction Abandoned AU2003251149A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0215389.8A GB0215389D0 (en) 2002-07-03 2002-07-03 Receptor
GB0215389.8 2002-07-03
PCT/GB2003/002859 WO2004005345A1 (en) 2002-07-03 2003-07-03 Inhibitors of the ephrin/ephb receptor interaction

Publications (1)

Publication Number Publication Date
AU2003251149A1 true AU2003251149A1 (en) 2004-01-23

Family

ID=9939780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003251149A Abandoned AU2003251149A1 (en) 2002-07-03 2003-07-03 Inhibitors of the ephrin/ephb receptor interaction

Country Status (3)

Country Link
AU (1) AU2003251149A1 (en)
GB (1) GB0215389D0 (en)
WO (1) WO2004005345A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070012818A (en) * 2004-05-06 2007-01-29 아벤티스 파마슈티칼스 인크. Treatment of demyelination disease
US20080112954A1 (en) * 2006-11-10 2008-05-15 Parker College Of Chiropractic Method for treating chronic pain
US7968517B2 (en) * 2008-10-31 2011-06-28 Parker College Of Chiropractic Method for treating withdrawal symptoms due to opiate consumption

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9024198A (en) * 1997-08-19 1999-03-08 Vanderbilt University Methods for determining cell responses through ephb receptors
ES2242437T3 (en) * 1998-11-20 2005-11-01 Genentech, Inc. USES OF AGONISTS AND ANTAGONISTS OF THE EPH RECEIVER FOR THE TREATMENT OF VASCULAR DISORDERS.
ZA200108038B (en) * 2000-10-02 2003-04-01 Pfizer Prod Inc Prophylactic use of n-methyl-d-asparrate (NMDA) antagonists.

Also Published As

Publication number Publication date
GB0215389D0 (en) 2002-08-14
WO2004005345A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2003303483A1 (en) Ccr8 inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003252998A1 (en) Well abandonment apparatus
AU2003288640A1 (en) Benzamide inhibitors of the p2x7 receptor
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2003299883A1 (en) Ccr8 inhibitors
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003289386A1 (en) Jnk inhibitors
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2003277674A1 (en) Novel parp inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003233426A1 (en) Corrosion inhibitor
AU2003301216A1 (en) Novel use of liver x receptor agonists
AU2003227899A1 (en) Tubing anchor
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003302588A1 (en) Phosphodiesterase 10a inhibitors
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003244080A1 (en) Phosphodiesterase inhibitor
AU2003234925A1 (en) TGF-Alpha EXPRESSION INHIBITORS